Phase 2 CLDN18.2 Positive Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
Pancreatic Ductal AdenocarcinomaGastric/Gastroesophageal Junction AdenocarcinomaCLDN18.2 Positive
Innovent Biologics (Suzhou) Co. Ltd.389 enrolled1 locationNCT07483554
Recruiting
Phase 2
IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of Resectable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction AdenocarcinomaCLDN18.2 PositivePrimary Gastric Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd.90 enrolled1 locationNCT07483567